Shashi Gujar

10PUBLICATIONS
46CO-AUTHORS
Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 17, 2024
Multiprong CD38 targeting to enhance anti-PD1 immune checkpoint blockade efficacy.

Vishnu Vijay Vijayan, Preethi Gopalakrishnan Nair, Shashi Gujar

|Sep 08, 2021
Autoimmunity affecting the biliary tract fuels the immunosurveillance of cholangiocarcinoma.

Juliette Paillet, Céleste Plantureux, Sarah Lévesque

|Dec 31, 2019
Quantitative Proteome Responses to Oncolytic Reovirus in GM-CSF- and M-CSF-Differentiated Bone Marrow-Derived Cells.

Michael A Giacomantonio, Andra M Sterea, Youra Kim

|May 17, 2019
Therapy-Induced MHC I Ligands Shape Neo-Antitumor CD8 T Cell Responses during Oncolytic Virus-Based Cancer Immunotherapy.

J Patrick Murphy, Youra Kim, Derek R Clements

Pageof 2